Gilpin Wealth Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$166K Buy
426
+6
+1% +$2.39K 0.11% 150
2026
Q2
$162K Buy
420
+314
+296% +$116K 0.11% 148
2026
Q1
$31K Buy
106
+41
+63% +$13.5K 0.02% 222
2025
Q4
$22.8K Buy
+65
New +$22K 0.02% 228

Other funds holding ELV

Gilpin Wealth Management's ELV Position: Q3 2026 in Review

Gilpin Wealth Management increased its Elevance Health (ELV) stake by 1.4% in Q3 2026, buying an estimated $2.39K and bringing the position to 426 shares worth $166K. The position accounts for 0.11% of the portfolio, ranked #150.

Gilpin Wealth Management first reported a position in ELV in Q4 2025 and has held it in 4 quarters since. 64 funds tracked by Wall St. Rank hold ELV as of Q3 2026.

  • Gilpin Wealth Management held 426 shares of Elevance Health worth $166K as of Q3 2026.
  • Gilpin Wealth Management bought 6 Elevance Health shares in Q3 2026, an estimated $2.39K.
  • Elevance Health made up 0.11% of Gilpin Wealth Management's portfolio in Q3 2026, its #150 holding.
  • Gilpin Wealth Management first reported a position in Elevance Health in Q4 2025 and has held it in 4 quarters since.
  • 64 funds tracked by Wall St. Rank held Elevance Health as of Q3 2026.

Based on Gilpin Wealth Management's 13F filing for Q3 2026, filed 9 Oct 2026.